Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation

• Verfasst von: Widholz, Benedikt [VerfasserIn]
• Verfasst von: Tsitlakidis, Stefanos [VerfasserIn]
• Verfasst von: Reible, Bruno [VerfasserIn]
• Verfasst von: Moghaddam-Alvandi, Arash [VerfasserIn]
• Verfasst von: Westhauser, Fabian [VerfasserIn]
• Titel: Pooling of patient-derived mesenchymal stromal cells reduces inter-individual confounder-associated variation without negative impact on cell viability, proliferation and osteogenic differentiation
• Verf.angabe: Benedikt Widholz, Stefanos Tsitlakidis, Bruno Reible, Arash Moghaddam and Fabian Westhauser
• E-Jahr: 2019
• Jahr: 24 June 2019
• Umfang: 16 S.
• Fussnoten: Gesehen am 11.12.2019
• Titel Quelle: Enthalten in: Cells
• Ort Quelle: Basel : MDPI, 2012
• Jahr Quelle: 2019
• Band/Heft Quelle: 8(2019,6) Artikel-Nummer 633, 16 Seiten
• ISSN Quelle: 2073-4409
• DOI: doi:10.3390/cells8060633
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: bone tissue engineering
• Sach-SW: cell pooling
• Sach-SW: cell proliferation
• Sach-SW: donor-specific variability
• Sach-SW: human mesenchymal stromal cells
• Sach-SW: osteogenic differentiation
• K10plus-PPN: 1681681692
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

Patient-derived mesenchymal stromal cells (MSCs) play a key role in bone tissue engineering. Various donor-specific factors were identified causing significant variability in the biological properties of MSCs impairing quality of data and inter-study comparability. These limitations might be overcome by pooling cells of different donors. However, the effects of pooling on osteogenic differentiation, proliferation and vitality remain unknown and have, therefore, been evaluated in this study. MSCs of 10 donors were cultivated and differentiated into osteogenic lineage individually and in a pooled setting, containing MSCs of each donor in equal parts. Proliferation was evaluated in expansion (assessment of generation time) and differentiation (quantification of dsDNA content) conditions. Vitality was visualized by a fluorescence-microscopy-based live/dead assay. Osteogenic differentiation was assessed by quantification of alkaline phosphatase (ALP) activity and extracellular calcium deposition. Compared to the individual setting, generation time of pooled MSCs was shorter and proliferation was increased during differentiation with significantly lower variances. Calcium deposition was comparable, while variances were significantly higher in the individual setting. ALP activity showed high variance in both groups, but increased comparably during the incubation period. In conclusion, MSC pooling helps to compensate donor-dependent variability and does not negatively influence MSC vitality, proliferation and osteogenic differentiation.